References
- Agarwal A, Parekh N, Panner Selvam MK, Henkel R, Shah R, Homa ST, Ramasamy R, Ko E, Tremellen K, Esteves S, et al. 2019. Male oxidative stress infertility (MOSI): proposed terminology and clinical practice guidelines for management of idiopathic male infertility. World J Men’s Health. 37(3):296–312. doi:https://doi.org/10.5534/wjmh.190055
- Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA. 2018. Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 103(5):1715–1744.
- Centers for Disease Control and Prevention (2009). Infertility FAQs. [accessed 2012 Jun 11]. http://www.cdc.gov/reproductivehealth/infertility.
- Chehab M, Madala A, Trussell JC. 2015. On-label and off-label drugs used in the treatment of male infertility. Fertil Steril. 103(3):595–604. doi:https://doi.org/10.1016/j.fertnstert.2014.12.122.
- Chua ME, Escusa KG, Luna S, Tapia LC, Dofitas B, Morales M. 2013. Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric therapy for idiopathic male infertility: a meta-analysis. Andrology. 1(5):749–757. doi:https://doi.org/10.1111/j.2047-2927.2013.00107.x.
- Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HWG, Behre HM, Haugen TB, Kruger T, Wang C, Mbizvo MT, et al. 2010. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 16:231–245. doi:https://doi.org/10.1093/humupd/dmp048.
- Dabaja A, Schlegel PN. 2014. Medical treatment of male infertility. Transl Androl Urol. 3(1):2223–4683. doi:0.3978/j.issn.2223-4683.2014.01.06
- El Meliegy AE, Motawi A, El Salam MAA. Systematic review of hormone replacement therapy in the infertile man. Arab J Urol. 2017;16(1):140–147. doi:https://doi.org/10.1016/j.aju.2017.11.011
- Kumar N, Singh AK. 2015. Trends of male factor infertility, an important cause of infertility: a review of literature. J Hum Reprod Sci. 8(4):191–196. doi:https://doi.org/10.4103/0974-1208.170370.
- Menke A, Guallar E, Rohrmann S, Nelson WG, Rifai N, Kanarek N, Feinleib M, Michos ED, Dobs A, Platz EA, et al. 2010. Sex steroid hormone concentrations and risk of death in US men. AM J Epidemiol. 171:583–592. doi:https://doi.org/10.1093/aje/kwp415.
- Mohamed O, Freundlich RE, Dakik HK, Grober ED, Najari B, Lipshultz LI, Khera M. 2010. The quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism. Int J Impot Res. 22(1):20–24. doi:https://doi.org/10.1038/ijir.2009.35.
- Mulhall JP, Trost LW, Brannigan RE, Kurtz EG, Redmon JB, Chiles KA, Lightner DJ, Miner MM, Murad MH, Nelson CJ, et al. 2018. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 200:423–432. doi:https://doi.org/10.1016/j.juro.2018.03.115.
- Patankar SS, Kaore SB, Sawane MV, Mishra NV, Deshkar AM. 2007. Effect of clomiphene citrate on sperm density in male partners of infertile couples. Indian J Physiol Pharmacol. 51(2):195–198.
- Practice Committee for the American Society for Reproductive Medicine in collaboration with the Society for Male Reproduction and Urology. 2008. Androgen deficiency in the aging male. Fertil Steril. 90(suppl 3):S83–S87. doi:https://doi.org/10.1016/j.fertnstert.2008.08.094.
- Sigman M, Jarow JP. 1997. Endocrine evaluation of infertile men. Urology. 50:659–664. doi:https://doi.org/10.1016/S0090-4295(97)00340-3.
- Toh SH, Prathipati P, Motakis E, Kwoh CK, Yenamandra SP, Kuznetsov VA. 2011. A robust tool for discriminative analysis and feature selection in paired samples impacts the identification of the genes essential for reprogramming lung tissue to adenocarcinoma. BMC Genomics. 12(Suppl 3\(Suppl 3)):S24. doi:https://doi.org/10.1186/1471-2164-12-S3-S24.
- Travison TG, Vesper HW, Orwoll E, Wu F, Kaufman JM, Wang Y, Lapauw B, Fiers T, Matsumoto AM, Bhasin S, et al. 2017. Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe. J Clin Endocrinol Metab. 102(4):1161–1173. doi:https://doi.org/10.1210/jc.2016-2935
- Trussell JC, Coward RM, Santoro N, Stetter C, Kunselman A, Diamond MP, Hansen KR, Krawetz SA, Legro RS, Heisenleder D, et al. 2019. Association of low testosterone with semen parameters and live birth in men with unexplained infertility. Fertil Steril. 111:1129–1134. doi:https://doi.org/10.1016/j.fertnstert.2019.01.034.
- Usadi RS, Merriam KS. 2015. On-label and off-label drug use in the treatment of female infertility. Fertil Steril. 103(3):583–594. doi:https://doi.org/10.1016/j.fertnstert.2015.01.011.
- Wheeler KM, Sharma D, Kavoussi PK, Smith RP, Costabile R. 2019. Clomiphene citrate for the treatment of hypogonadism. Sex Med Rev. 7:272–276. doi:https://doi.org/10.1016/j.sxmr.2018.10.001.
- Willets AE, Crobo JM, Brown JN. 2013. Clomiphene for the treatment of male infertility. Reprod Sci. 20(7):739–744. doi:https://doi.org/10.1177/1933719112466304.